Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

Fintel reports that on November 4, 2024, Piper Sandler downgraded their outlook for ESSA Pharma (NasdaqCM:EPIX) from ...

In a report released today, Peter Keith from Piper Sandler maintained a Hold rating on Dollar Tree (DLTR – Research Report), with a price ...

Piper Sandler analyst Alexander Goldfarb maintained a Buy rating on Lineage, Inc. (LINE – Research Report) today and set a price target ...

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

The British drugmaker’s unit RBP Global Holdings Ltd. signed up with Piper Sandler Finance LLC and certain buyers for $400 ...

NEW YORK - Piper Sandler Companies (NYSE: PIPR), a prominent investment bank, and BC Partners Credit have announced a strategic alliance aimed at enhancing debt capital market access for financial ...

Piper Sandler raised the firm’s price target on Mondelez (MDLZ) to $84 from $74 and keeps an Overweight rating on the shares. The firm notes Mondelez reported better than expected Q3 EPS and ...

NEW YORK - Piper Sandler Companies (NYSE: PIPR), a prominent investment bank, and BC Partners Credit have announced a strategic alliance aimed at enhancing debt capital market access for financial ...

Alerus Financial (NASDAQ:ALRS – Get Free Report) had its price objective lowered by analysts at Piper Sandler from $24.00 to $23.00 in a research note issued on Thursday, Benzinga reports.